IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $534,398 | +63067.6% | 55,493 | -25.2% | 0.00% | -57.1% |
Q4 2022 | $846 | -99.9% | 74,140 | -24.4% | 0.01% | -22.2% |
Q3 2022 | $1,031,000 | -30.1% | 98,127 | -22.1% | 0.01% | -25.0% |
Q2 2022 | $1,475,000 | -79.8% | 125,972 | -79.3% | 0.01% | -77.4% |
Q1 2022 | $7,305,000 | +8.8% | 607,247 | +0.7% | 0.05% | +8.2% |
Q4 2021 | $6,717,000 | +3.2% | 602,957 | +20.7% | 0.05% | +25.6% |
Q3 2021 | $6,510,000 | -3.6% | 499,587 | -3.9% | 0.04% | -2.5% |
Q2 2021 | $6,756,000 | +110.6% | 519,697 | +79.8% | 0.04% | +110.5% |
Q1 2021 | $3,208,000 | +52.9% | 288,977 | +42.4% | 0.02% | +46.2% |
Q4 2020 | $2,098,000 | +223.8% | 202,866 | +201.9% | 0.01% | +160.0% |
Q3 2020 | $648,000 | +27.6% | 67,196 | +30.9% | 0.01% | +25.0% |
Q2 2020 | $508,000 | -16.2% | 51,323 | -12.9% | 0.00% | -33.3% |
Q1 2020 | $606,000 | – | 58,922 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |